WuXi PharmaTech (Shanghai, China) has appointed Peng Wang, PhD as vice president of discovery biology. Prior to joining WuXi PharmaTech, Wang was a research fellow at the Schering-Plough Research Institute, where he worked for 18 years. He has extensive experience in discovery biology, including target validation research, assay development, screening, 

 biological and  pharmacological studies, and biomarker research. In his new role, Wang will oversee the WuXi PharmaTech’s portfolio of discovery biology service offerings. 

News

WuXi PharmaTech (Shanghai, China) has appointed Peng Wang, PhD as vice president of discovery biology.